Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $29.3700 (-2.94%) ($29.3700 - $29.3700) on Mon. Apr. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 38 | Latest Price | $29.3700(-2.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.7% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(40%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.925% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $21.96(-25.23%) | Resistance Level | $31.22 | 5 Day Moving Average | $30.78(-4.58%) | 10 Day Moving Average | $30.91(-4.98%) | 20 Day Moving Average | $31.22(-5.93%) | To recent high | -44.2% | To recent low | 2.5% | Market Cap | $4.301b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |